John Allan
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
- Arsenal extend lead, Villa stun City in tight Premier League clash
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Controversial Israeli bills aim to halt Netanyahu's trial and block Bennett's election bid, sparking concerns over democracy and rule of law.
- Arsenal extend lead, Villa stun City in tight Premier League clash
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from John Allan
News from John Allan
